Baxter Healthcare S.A.
608 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 16 name spellings.
59
Ending by 2030
Jan 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 2, 2026The maintenance fee for Method for delivering drugs to the brain (US 9,044,381) comes due Dec 2, 2026. Unpaid by Jun 2, 2027, it lapses early.
- 8 fees due Jan 2 to 25, 2027 · next Jan 2
- 9 fees due Feb 1 to 28, 2027 · next Feb 1
- 7 fees due Mar 8 to 29, 2027 · next Mar 8
- 11 fees due Apr 1 to 29, 2027 · next Apr 1
- 3 fees due May 10 to 21, 2027 · next May 10
- 9 fees due Jun 5 to 29, 2027 · next Jun 5
- 2 fees due Jul 12 to 30, 2027 · next Jul 12
- 3 fees due Aug 2 to 16, 2027 · next Aug 2
- 3 fees due Sep 8 to 19, 2027 · next Sep 8
- 10 fees due Oct 2 to 28, 2027 · next Oct 2
- 5 fees due Nov 7 to 17, 2027 · next Nov 7
Recent changes
- 14 of the patents on this record were granted since Aug 23, 2026
- Nov 17 US 12,798,816 Method and System for Producing Sterile Solution Filled Containers
- Nov 17 US 12,797,072 Collagen Matrix and N-Hydroxylsuccinimide Functionalized Polyethylene Glycol Staple Line Reinforcement
- Nov 10 US 12,791,097 Infusion Pump Door Seal for Vertical Intravenous Tubes
- Nov 10 US 12,790,246 System and Method for Producing Microbiologically Controlled Fluid
- Nov 3 US D1,156,662 Pharmacy Workflow Cart for Medication Dose Preparation
- Nov 3 US 12,779,010 Vasopressin Premix Systems and Uses Thereof
- Nov 3 US 12,778,918 Parenteral Nutrition Formulation
- Oct 13 US D1,153,675 Infusion Pump
- Oct 6 US D1,152,032 Multi-Stage Infusion Pump Hub
- Sep 29 US 12,746,326 Systems and Methods for Controlling Pulse Mode Pumping in Infusion Systems
- Sep 1 US 12,721,859 Pharmaceutically Acceptable Ready-To-Use Ferric Carboxymaltose Compositions
- Aug 25 US 12,715,643 Method and System for Producing Sterile Solution Filled Containers
- Aug 25 US 12,714,725 Stabilization of Selenite in a Nutritional Solution by Dissolved Oxygen
- Aug 25 US 12,714,681 Packaged, Sealed Container System for Stable Storage of an Oxygen Sensitive Pharmaceutical Formulation
- 17 terms have ended since Aug 23, 2026
- Nov 20 US 8,333,959 Ex-Vivo Application of Solid Microparticulate Therapeutic Agents · term ended
- Nov 14 US 7,642,271 Argatroban Formulation · term ended
- Nov 6 US 7,776,360 (POLYALKOXY)SULFONATE Surface Modifiers · term ended
- Oct 28 US 8,871,949 Method for Preparing Fmoc-Based Hydrolysable Linkers · lapsed on the fee record
- Oct 25 US 7,733,892 Buffer Management Method Based on a Bitmap Table · term ended
- Oct 21 US 8,868,350 Therapy Prediction and Optimization for Renal Failure Blood Therapy, Especially Home Hemodialysis · lapsed on the fee record
- Oct 21 US 8,865,450 Method for Producing Continuous Cell Lines · lapsed on the fee record
- Oct 19 US 7,699,806 Medical Fluid Therapy Flow Balancing and Synchronization Method and Apparatus · term ended
- Oct 14 US 8,858,792 Hemodialysis and Peritoneal Dialysis Systems Having Electrodeionization Capabilities · lapsed on the fee record
- Oct 14 US 8,858,787 Dialysis System Having Non-Invasive Fluid Velocity Sensing · lapsed on the fee record
- Sep 30 US 8,846,620 Resorption Enhancers as Additives to Improve the Oral Formulation of Non-Anticoagulant Sulfated Polysaccharides · lapsed on the fee record
- Sep 23 US 8,841,248 Manufacture of Inter-Alpha-Inhibitor (IaIp) from Plasma · lapsed on the fee record
- Sep 10 US 11,124,787 ADAMTS13-Containing Compositions Having Thrombolytic Activity · term ended
- Sep 2 US 8,822,638 Biologically Active Peptides · lapsed on the fee record
- Aug 28 US 8,034,830 Argatroban Formulation · term ended
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,762,795 | Rotary Axial Peristaltic Pumps and Related Methods In force · High confidence | In force | High confidence | |
| US 7,537,174 | Hand Triggered Tissue Sealant Spray Apparatus and System In force · High confidence | In force | High confidence | |
| US 11,896,939 | Device, System and Method for Mixing In force · High confidence | In force | High confidence | |
| US 9,821,001 | Novel Aminoglycosides and Uses Thereof in the Treatment of Genetic Disorders In force · Low confidence | In force | Low confidence | |
| US 8,703,122 | Method for Directed Cell In-Growth and Controlled Tissue Regeneration in Spinal Surgery In force · High confidence | In force | High confidence | |
| US 8,834,864 | Methods for repairing and regenerating human dura mater In force · High confidence | In force | High confidence | |
| US 8,722,736 | Multi-Dose Concentrate Esmolol with Benzyl Alcohol In force · High confidence | In force | High confidence | |
| US 7,605,291 | Method for the Preparation of Volatile Anesthetics In force · High confidence | In force | High confidence | |
| US 10,166,514 | Device, System and Method for Mixing In force · High confidence | In force | High confidence | |
| US 9,724,449 | Injectable Fibrin Composition for Bone Augmentation In force · High confidence | In force | High confidence |
Also on record, not counted in the 381: 608 patents in force now held by others · 303 lapsed for an unpaid fee · 380 ended at full term · 2 past the fee grace period · 3 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
133 pending · 246 abandoned · 14 no status recorded